Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Financing Activities (2018 - 2025)

Neurogene (NGNE) has disclosed Cash from Financing Activities for 5 consecutive years, with $9.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 7312.21% year-over-year to $9.7 million, compared with a TTM value of $199.8 million through Sep 2025, up 7774.08%, and an annual FY2024 reading of $184.1 million, up 99.03% over the prior year.
  • Cash from Financing Activities was $9.7 million for Q3 2025 at Neurogene, up from $54000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $190.1 million in Q4 2024 and bottomed at -$6.5 million in Q1 2024.